Investor Status. At the time Investor was offered the Securities, it was, and it is: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Act.
Appears in 7 contracts
Samples: Securities Purchase Agreement (NYXIO TECHNOLOGIES Corp), Securities Purchase Agreement (Bionovo Inc), Securities Purchase Agreement (Marina Biotech, Inc.)
Investor Status. At the time Investor was offered the Securities, it was, and at the Effective Date it is: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Act.
Appears in 5 contracts
Samples: Preferred Stock Purchase Agreement (International Stem Cell CORP), Preferred Stock Purchase Agreement (Cord Blood America, Inc.), Preferred Stock Purchase Agreement (Iceweb Inc)
Investor Status. At the time the Investor was offered the SecuritiesStock, it was, and as of the date hereof it isis either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act. The Investor is not required to be registered as a broker-dealer under Section 15 of the Exchange Act.
Appears in 3 contracts
Samples: License, Development and Commercialization Agreement (Ignyta, Inc.), License, Development and Commercialization Agreement (Ignyta, Inc.), License, Development and Commercialization Agreement (Ignyta, Inc.)
Investor Status. At the time such Investor was offered the Securities, it was, and as of the date hereof it is: (i) is an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(4), (a)(5), (a)(6), (a)(7), (a)(8), (a)(9), (a)(12) or (a)(8a)(13) under the Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act.
Appears in 2 contracts
Samples: Securities Purchase Agreement (In8bio, Inc.), Securities Purchase Agreement (In8bio, Inc.)
Investor Status. At the time such Investor was offered the SecuritiesShares, it was, and as of the date hereof it is: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(5), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act. Such Investor is not a registered broker-dealer under Section 15 of the Exchange Act.
Appears in 1 contract
Investor Status. At the time the Investor was offered the Securities, it was, and as of the date hereof it is, either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act.
Appears in 1 contract
Samples: Securities Purchase Agreement (Ascent Solar Technologies, Inc.)
Investor Status. At the time the Investor was offered the Securities, it was, and as of the date hereof it is, either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) ), (a)(8), (a)(9), (a)(12), or (a)(8a)(13) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act.
Appears in 1 contract
Samples: Securities Purchase Agreement (Healthcare Triangle, Inc.)
Investor Status. At the time the Investor was offered the SecuritiesShares, it was, and as of the date hereof it isis either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act. Such Investor is not required to be registered as a broker-dealer under Section 15 of the Exchange Act.
Appears in 1 contract
Samples: Securities Purchase Agreement (China TransInfo Technology Corp.)
